Saudi Food and Drug Authority Suspends The Authorisation of Rosiglitazone 01 Rabe'a Al-Thani 1431 (H) Equal 17 March 2010 (G)The Saudi food and Drug Authority has reviewed the safety of Rosiglitazone (Avandia®) which used in treatment of type 2 diabetes mellitus and marketed in Saudi Arabia as Avandia®. Based on growing evidence from clinical trials meta-analyses and observational studies indicating serious cardiovascular adverse ..more
In Collaboration with SFDA: King Faisal Specialist Hospital & Research Center Inaugurates the International Radiology Conference 16 Rabe'a Al-Wal 1431 (H) Equal 2 March 2010 (G)In the presence of H.E Chief Executive Officer of the Saudi Food & Drug Authority and H.E Dr. Qassim Al Qassabi, General Executive Supervisor of KFSH&RC, the International Radiology Conference and Exhibition was inaugurated ..more
Saudi FDA alerts Hospitals & Health Care Providers about using Blood Sugar Test Tapes type ' One Touch Sure Step' 14 Rabe'a Al-Wal 1431 (H) Equal 28 February 2010 (G)In accordance with Saudi food and drug authority efforts, represented by the National Center for medical devices reporting through its surveillance for the quality and safety of medical devices marketed in Saudi Arabia. Saudi FDA alerts ..more
Saudi FDA organizes a workshop on "SPS and their Mechanism" at WTO 14 Rabe'a Al-Wal 1431 (H) Equal 28 February 2010 (G)The Saudi FDA, represented by Food Sector, organizes a workshop on 'SPS and their Mechanism' at WTO on Monday 15/03/1431 AH, corresponding to the 1st. of March 2010G at SFDA main Auditorium starting ..more
Saudi FDA Cancels the Registration of Aupent Product 01 Rabe'a Al-Wal 1431 (H) Equal 15 February 2010 (G)The Saudi FDA has announced the cancellation of Alupent® 10mg L 5 mo syrup ( orciprenaline sulphate) registration due to its hazards on heart and the availability of more safe alternative drugs.Accordingly, drug products and manufacturers' registration committee decided ..more